Glenmark Pharma to present updated info on GBR 830 at International Investigative Dermatology…
GBR 830 is a first-in-class, investigational, anti-OX40 monoclonal antibody for treatment of moderate-to-severe atopic dermatitis
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.